4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-010137
Dake Benjamin T sold 3,325 shares at $31.97 ($106,317)
- Dake Benjamin T acquired 3,325 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,325 | $10.61 | $35,278 | 4,616 | D |
| 2024-04-01 | Sale : show line 2 in the form 10b5-1 | −3,325 | $31.97 | $106,317 | 1,291 | D |
| Open-market sales · 3,325 sh · avg $31.97 · $106,317 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −3,325 | 25,675 | D |
Loading xslF345X05/form4-04032024_060406.xml…